Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
- Conditions
- Panic Disorder
- Registration Number
- NCT00515996
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
- Panic disorder
Exclusion Criteria
- Other major medical or psychiatric illnesses
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Samsung Medical Center
🇰🇷Seoul, Korea, Republic of